SCHEMBL4607170

SCHEMBL4607170

CC(=O)Nc1cccc(-c2ccc(C3CCCC3C(N)=O)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.52
GRIA2 P42262 2/20 0.50
KCNH2 Q12809 1/20 0.50
KDM1A O60341 2/20 0.48
CYP17A1 P05093 2/20 0.48
CYP11B1 P15538 1/20 0.48
CYP11B2 P19099 1/20 0.48
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
PARP1 P09874 1/20 0.46
DHODH Q02127 1/20 0.46
MAP4K4 O95819 1/20 0.46
ALDH1A1 P00352 1/20 0.45
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
PTGIR P43119 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
AAK1 Q2M2I8 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607172 0.86 KDM1A (0.56) BACE1GRIA2KCNH2KDM1ACYP17A1
SCHEMBL4605913 0.84 KDM1A (0.64) GRIA2KCNH2KDM1ASLC6A2SLC6A4
SCHEMBL4606553 0.79 SLC6A2 (0.61) KDM1ASLC6A2SLC6A4
SCHEMBL7250833 0.76 GRIA2 (0.74) GRIA2KCNH2KDM1A
SCHEMBL4607084 0.76 GRIA2 (0.74) GRIA2KCNH2KDM1A
SCHEMBL7250835 0.76 GRIA2 (0.74) GRIA2KCNH2KDM1A
SCHEMBL8577619 0.73 SMN1; SMN2 (0.70) CYP17A1CYP11B1CYP11B2ALDH1A1HSD17B1
SCHEMBL4654909 0.72 ALDH1A1 (0.67) CYP17A1CYP11B1CYP11B2MAP4K4ALDH1A1
SCHEMBL4604971 0.72 SLC6A2 (0.52) KDM1ASLC6A2SLC6A4PARP1
SCHEMBL3786463 0.72 NQO2 (0.73) CYP17A1CYP11B1CYP11B2ALDH1A1HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed